Evidence map›Paper›PMID 27128603›Full record

ReviewRNA biology2016

7SKiing on chromatin: Move globally, act locally.

Iván D'Orso

Open access · bronzeAbstract readReview
In one paragraph

Review in RNA biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. A (Scientific) Lifetime Affair With Nucleic Acids.Journal of molecular biology · 2025
    Review
  3. KAP1 in antiviral immunity: dual roles in viral silencing and immune regulation.Frontiers in cellular and infection microbiology · 2025
    Review
  4. Review
  5. Article
  6. Article
  7. An alternative D. melanogaster 7SK snRNP.BMC molecular and cell biology · 2021
    Article
  8. CDK9 keeps RNA polymerase II on track.Cellular and molecular life sciences : CMLS · 2021
    Review
  9. Review
  10. Review
  11. Review
  12. KAP1 targets actively transcribed genomic loci to exert pleomorphic effects on RNA polymerase II activity.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2020
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Tandem Affinity Purification of Protein Complexes from Eukaryotic Cells.Journal of visualized experiments : JoVE · 2017
    Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Iván D'Orsoa Department of Microbiology , The University of Texas Southwestern Medical Center , Dallas , TX , USA.
The University of Texas Southwestern Medical Center · US

Funding

Transcriptional regulatory mechanisms shaping HIV proviral fateR01AI114362 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI D'ORSO, IVAN · 2015 to 2024
$4.6M
Transcriptional regulatory mechanisms shaping HIV proviral fateR37AI114362 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI Ivan D'Orso · 2025 to 2026
$1.0M
NIAID NIH HHS R37 AI114362
6 · The paper itself

Abstract

RNA polymerase II (Pol II) pausing at promoter-proximal regions is a highly regulated step in the transcription cycle. Pause release is facilitated by the P-TEFb kinase, which phosphorylates Pol II and negative elongation factors. Recent studies suggest that P-TEFb (as part of the inhibitory 7SK snRNP) is recruited to promoter-proximal regions through interaction with KAP1/TRIM28/TIF1β to facilitate 'on-site' kinase activation and transcription elongation. Here, I discuss features of this model and future challenges to further hone our understanding of transcriptional regulation including Pol II pausing and pause release.

Indexed as

ChromatinHEK293 CellsHeLa CellsHumansPhosphorylationPositive Transcriptional Elongation Factor BPromoter Regions, GeneticRNA Polymerase IITranscription FactorsTranscription, GeneticChromatinnegative elongation factorPositive Transcriptional Elongation Factor BRNA Polymerase IITranscription Factors7SK snRNPKAP1/TRIM28P-TEFbRNA polymerase IItranscription elongation

Identifiers

PMID27128603
PMCPMC4962805
OpenAlexW2342959309

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.